Transmural heterogeneity and remodeling of ventricular excitation- contraction coupling in human heart failure

Circulation

Volumn 123, Issue 17, 2011, Pages 1881-1890

  Lou, Qing ^a   Fedorov, Vadim V ^a   Glukhov, Alexey V ^a   Moazami, Nader ^b   Fast, Vladimir G ^c   Efimov, Igor R ^a  

^a WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

action potentials; calcium; excitation contraction coupling; heart failure; ventricular remodeling

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CA2+ ATPASE 2A; PHOSPHOLAMBAN; SARCOPLASMIC RETICULUM CALCIUM ATPASE 2A; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART CONTRACTION; HEART EXCITATION; HEART FAILURE; HEART MUSCLE POTENTIAL; HEART VENTRICLE REMODELING; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOPLASMIC RETICULUM;

EID: 85027934254     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.989707     Document Type: Article

References (41)

1. American Heart Association. Heart disease and stroke statistics: 2009 update. Circulation. 2009;119:e21-e181.
2. Piacentino V 3rd, Weber CR, Chen X, Weisser-Thomas J, Margulies KB, Bers DM, Houser SR. Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ Res. 2003;92:651-658. (Pubitemid 36417700)
3. Sjaastad I, Wasserstrom JA, Sejersted OM. Heart failure: a challenge to our current concepts of excitation-contraction coupling. J Physiol. 2003; 546:33-47.
4. Bers DM. Cardiac excitation-contraction coupling. Nature. 2002;415: 198-205. (Pubitemid 34059525)
5. Benitah JP, Kerfant BG, Vassort G, Richard S, Gomez AM. Altered communication between L-type calcium channels and ryanodine receptors in heart failure. Front Biosci. 2002;7:e263-e275.
6. Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W, Morgan JP. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res. 1987; 61:70-76. (Pubitemid 17133480)
7. Morgan JP, Erny RE, Allen PD, Grossman W, Gwathmey JK. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation. 1990;81(suppl):III-21-III-32.
8. Morgan JP. Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med. 1991;325: 625-632.
9. Beuckelmann DJ, Nabauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation. 1992;85:1046-1055.
10. Hasenfuss G, Mulieri LA, Leavitt BJ, Allen PD, Haeberle JR, Alpert NR. Alteration of contractile function and excitation-contraction coupling in dilated cardiomyopathy. Circ Res. 1992;70:1225-1232.
11. Hasenfuss G, Pieske B, Holubarsch C, Alpert NR, Just H. Excitationcontraction coupling and contractile protein function in failing and nonfailing human myocardium. Adv Exp Med Biol. 1993;346:91-100. (Pubitemid 24048716)
12. Vahl CF, Bonz A, Timek T, Hagl S. Intracellular calcium transient of working human myocardium of seven patients transplanted for congestive heart failure. Circ Res. 1994;74:952-958. (Pubitemid 24121599)
13. Pieske B, Kretschmann B, Meyer M, Holubarsch C, Weirich J, Posival H, Minami K, Just H, Hasenfuss G. Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation. 1995;92:1169-1178.
14. Cordeiro JM, Greene L, Heilmann C, Antzelevitch D, Antzelevitch C. Transmural heterogeneity of calcium activity and mechanical function in the canine left ventricle. Am J Physiol Heart Circ Physiol. 2004;286: H1471-H1479. (Pubitemid 38381157)
15. Laurita KR, Katra R, Wible B, Wan X, Koo MH. Transmural heterogeneity of calcium handling in canine. Circ Res. 2003;92:668-675. (Pubitemid 36417702)
16. Glukhov AV, Fedorov VV, Lou Q, Ravikumar VK, Kalish PW, Schuessler RB, Moazami N, Efimov IR. Transmural dispersion of repolarization in failing and nonfailing human ventricle. Circ Res. 2010;106: 981-991.
17. Prestle J, Dieterich S, Preuss M, Bieligk U, Hasenfuss G. Heterogeneous transmural gene expression of calcium-handling proteins and natriuretic peptides in the failing human heart. Cardiovasc Res. 1999;43:323-331. (Pubitemid 29356370)
18. Wilson LD, Jeyaraj D, Wan X, Hoeker GS, Said TH, Gittinger M, Laurita KR, Rosenbaum DS. Heart failure enhances susceptibility to arrhythmogenic cardiac alternans. Heart Rhythm. 2009;6:251-259.
19. Laurita KR, Katra RP. Delayed after depolarization-mediated triggered activity associated with slow calcium sequestration near the endocardium. J Cardiovasc Electrophysiol. 2005;16:418-424.
20. Fedorov VV, Lozinsky IT, Sosunov EA, Anyukhovsky EP, Rosen MR, Balke CW, Efimov IR. Application of blebbistatin as an excitationcontraction uncoupler for electrophysiologic study of rat and rabbit hearts. Heart Rhythm. 2007;4:619-626. (Pubitemid 46630372)
21. O'Rourke B, Kass DA, Tomaselli GF, Kaab S, Tunin R, Marban E. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: experimental studies. Circ Res. 1999; 84:562-570. (Pubitemid 29138593)
22. Wasserstrom JA, Sharma R, Kapur S, Kelly JE, Kadish AH, Balke CW, Aistrup GL. Multiple defects in intracellular calcium cycling in whole failing rat heart. Circ Heart Fail. 2009;2:223-232.
23. Burashnikov A, Antzelevitch C. Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity. Circulation. 2003; 107:2355-2360. (Pubitemid 36578508)
24. Ogawa M, Morita N, Tang L, Karagueuzian HS, Weiss JN, Lin SF, Chen PS. Mechanisms of recurrent ventricular fibrillation in a rabbit model of pacing-induced heart failure. Heart Rhythm. 2009;6:784-792.
25. Ashikaga H, Coppola BA, Hopenfeld B, Leifer ES, McVeigh ER, Omens JH. Transmural dispersion of myofiber mechanics: implications for electrical heterogeneity in vivo. J Am Coll Cardiol. 2007;49:909-916. (Pubitemid 46275356)
26. Bohm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet. 2010;376:886-894.
27. 2 exchanger in end-stage human heart failure. Circ Res. 1994;75:443-453.
28. Hasenfuss G, Reinecke H, Studer R, Meyer M, Pieske B, Holtz J, Holubarsch C, Posival H, Just H, Drexler H. Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2)-ATPase in failing and nonfailing human myocardium. Circ Res. 1994;75:434-442.
29. Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, Posival H, Kuwajima G, Mikoshiba K, Just H, Hasenfuss G. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation. 1995;92:778-784.
30. 2-handling in failing human myocardium. J Mol Cell Cardiol. 2001;33:1345-1353. (Pubitemid 32613426)
31. 2ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy. J Mol Med. 1996;74:321-332.
32. Frank K, Bolck B, Bavendiek U, Schwinger RH. Frequency dependent force generation correlates with sarcoplasmic calcium ATPase activity in human myocardium. Basic Res Cardiol. 1998;93:405-411. (Pubitemid 28499461)
33. Linck B, Boknik P, Eschenhagen T, Muller FU, Neumann J, Nose M, Jones LR, Schmitz W, Scholz H. Messenger RNA expression and immunological quantification of phospholamban and SR-Ca(2)-ATPase in failing and nonfailing human hearts. Cardiovasc Res. 1996;31:625-632.
34. Movsesian MA, Karimi M, Green K, Jones LR. Ca(2)-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation. 1994;90:653-657.
35. 2-ATPase, phospholamban, and calsequestrin in terminally failing human myocardium. J Mol Med. 1998;76:434-441. (Pubitemid 28218645)
36. Schmidt U, Hajjar RJ, Kim CS, Lebeche D, Doye AA, Gwathmey JK. Human heart failure: cAMP stimulation of SR Ca(2)-ATPase activity and phosphorylation level of phospholamban. Am J Physiol. 1999;277: H474-H480. (Pubitemid 29415959)
37. 2 uptake and Ca(2)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation. 1995;92: 3220-3228.
38. Sen L, Cui G, Fonarow GC, Laks H. Differences in mechanisms of SR dysfunction in ischemic vs. idiopathic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2000;279:H709-H718.
39. Nef HM, Mollmann H, Akashi YJ, Hamm CW. Mechanisms of stress (Takotsubo) cardiomyopathy. Nat Rev Cardiol. 2010;7:187-193.
40. Fast VG, Cheek ER, Pollard AE, Ideker RE. Effects of electrical shocks on Cai 2 and Vm in myocyte cultures. Circ Res. 2004;94:1589-1597.
41. Fast VG. Simultaneous optical imaging of membrane potential and intracellular calcium. J Electrocardiol. 2005;38:107-112.